ArticleUpdates in surgery2025
Development of a predictive model for lung metastasis in hepatocellular carcinoma patients: insights from SEER database analysis.
Article in Updates in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality globally, with lung metastasis significantly impacting patient prognosis. Identifying predictors of lung metastasis is crucial for improving patient outcomes. This study utilizes data from the Surveillance Epidemiology and End Results (SEER) database, focusing on a cohort of 13,441 HCC patients. We examined various demographic and clinical factors, employing logistic regression and nomogram analysis to develop a predictive model for lung metastasis. The model's effectiveness was validated using receiver operating characteristic (ROC) curve and calibration analyses. Key factors such as tumor grade, size, stage, and lymph node stage were identified as significant predictors of lung metastasis. The predictive model demonstrated high accuracy, with area under the ROC curve (AUC) values of 0.803 in the training set and 0.783 in the validation set. Calibration plots confirmed the model's reliability in predicting lung metastasis. Our predictive model provides a robust tool for risk stratification and therapeutic planning in HCC patients, aiding clinical decision-making. This study highlights the potential of data-driven approaches in enhancing patient care and advancing HCC management.
Indexed as
Identifiers
40782182What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.